143 related articles for article (PubMed ID: 21368573)
1. p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program.
Pang LY; Scott M; Hayward RL; Mohammed H; Whitelaw CB; Smith GC; Hupp TR
Cell Cycle; 2011 Mar; 10(6):932-50. PubMed ID: 21368573
[TBL] [Abstract][Full Text] [Related]
2. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
Lo PK; Lee JS; Sukumar S
Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
[TBL] [Abstract][Full Text] [Related]
3. UVB-Induced p21 degradation promotes apoptosis of human keratinocytes.
Lei X; Liu B; Han W; Ming M; He YY
Photochem Photobiol Sci; 2010 Dec; 9(12):1640-8. PubMed ID: 20931139
[TBL] [Abstract][Full Text] [Related]
4. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
5. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
[TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
Lin K; Rockliffe N; Johnson GG; Sherrington PD; Pettitt AR
Oncogene; 2008 Apr; 27(17):2445-55. PubMed ID: 17982489
[TBL] [Abstract][Full Text] [Related]
10. Arecoline-induced phosphorylated p53 and p21(WAF1) protein expression is dependent on ATM/ATR and phosphatidylinositol-3-kinase in clone-9 cells.
Chou WW; Guh JY; Tsai JF; Hwang CC; Chiou SJ; Chuang LY
J Cell Biochem; 2009 Jun; 107(3):408-17. PubMed ID: 19343784
[TBL] [Abstract][Full Text] [Related]
11. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback.
Wagner J; Ma L; Rice JJ; Hu W; Levine AJ; Stolovitzky GA
Syst Biol (Stevenage); 2005 Sep; 152(3):109-18. PubMed ID: 16986275
[TBL] [Abstract][Full Text] [Related]
12. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
[TBL] [Abstract][Full Text] [Related]
13. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
Bai L; Kao JY; Law DJ; Merchant JL
Gastroenterology; 2006 Sep; 131(3):841-52. PubMed ID: 16952553
[TBL] [Abstract][Full Text] [Related]
15. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
[TBL] [Abstract][Full Text] [Related]
16. Explaining oscillations and variability in the p53-Mdm2 system.
Proctor CJ; Gray DA
BMC Syst Biol; 2008 Aug; 2():75. PubMed ID: 18706112
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration.
Lin K; Adamson J; Johnson GG; Carter A; Oates M; Wade R; Richards S; Gonzalez D; Matutes E; Dearden C; Oscier DG; Catovsky D; Pettitt AR
Clin Cancer Res; 2012 Aug; 18(15):4191-200. PubMed ID: 22675167
[TBL] [Abstract][Full Text] [Related]
18. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
Cheng Q; Chen L; Li Z; Lane WS; Chen J
EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
20. DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction.
Wang Z; Inuzuka H; Zhong J; Fukushima H; Wan L; Liu P; Wei W
Oncotarget; 2012 Sep; 3(9):1026-35. PubMed ID: 22976441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]